Biology of Bone Metastases in Patients With mCRPC

Conor Lynch, PhD
Published: Monday, Sep 19, 2016



Conor Lynch, PhD, an associate professor of Tumor Biology at Moffitt Cancer Center, discusses the biology of bone metastases in patients with metastatic castration-resistant prostate cancer.

When prostate cancer metastasizes, it typically spreads to the bone, Lynch explains. Researchers at Moffitt Cancer Center, particularly in Lynch's lab, are investigating how cancer cells metastasize to the bone and how they interact with the bone environment in order to grow.

These metastases can lead to extensive bone formation, which are osteosclerotic types of lesions that often occur in areas of the patients who are weight-bearing. These can be extremely painful and greatly affect patient quality of life, he adds.


Conor Lynch, PhD, an associate professor of Tumor Biology at Moffitt Cancer Center, discusses the biology of bone metastases in patients with metastatic castration-resistant prostate cancer.

When prostate cancer metastasizes, it typically spreads to the bone, Lynch explains. Researchers at Moffitt Cancer Center, particularly in Lynch's lab, are investigating how cancer cells metastasize to the bone and how they interact with the bone environment in order to grow.

These metastases can lead to extensive bone formation, which are osteosclerotic types of lesions that often occur in areas of the patients who are weight-bearing. These can be extremely painful and greatly affect patient quality of life, he adds.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesJan 30, 20182.0
Medical Crossfire®: The Expanding Role of PARP Inhibitors in the Treatment of Ovarian Cancers – Current Strategies and Future DirectionJan 30, 20181.5
Publication Bottom Border
Border Publication
x